Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 11, 2019

SELL
$14.59 - $23.84 $277,647 - $453,675
-19,030 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$21.06 - $25.65 $8,424 - $10,260
400 Added 2.15%
19,030 $410,000
Q2 2018

Jul 24, 2018

SELL
$16.77 - $24.71 $26,563 - $39,140
-1,584 Reduced 7.84%
18,630 $453,000
Q1 2018

May 03, 2018

BUY
$16.68 - $22.07 $109,687 - $145,132
6,576 Added 48.22%
20,214 $345,000
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $153,154 - $260,485
13,638
13,638 $258,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.